Home › Research › How common it is
Global burden of young-onset dementia, from 1990 to 2021: an age-period-cohort analysis from the global burden of disease study 2021
He Q, Wang W, Zhang Y, Xiong Y, Tao C, Ma L, You C, Ma J, Jiang Y. Translational Psychiatry, 2025
Topic: Risk, prevention and care in population studies
Plain-language summary
Using three decades of global health data, this study tracked how young-onset dementia (before age 65) has changed since 1990. The raw number of cases more than tripled, mostly because there are simply more people in the 55-64 age range worldwide, while a person's underlying risk at a given age rose only slightly. Women carried a higher absolute burden than men, though men's rates were rising somewhat faster.
What this study adds
Evidence grade: Moderate
Using three decades of global health data, this study found that the raw number of young-onset dementia cases more than tripled, mostly because there are simply more people in the 55-64 age range worldwide, while a person's underlying risk at a given age rose only slightly. Its stated limit: Relies on modeled GBD estimates built from heterogeneous, often sparse underlying country-level data sources rather than uniformly collected primary surveillance data.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
He, Q., Wang, W., Zhang, Y., Xiong, Y., Tao, C., Ma, L., et al. (2025). Global burden of young-onset dementia, from 1990 to 2021: an age-period-cohort analysis from the global burden of disease study 2021. Translational Psychiatry. https://doi.org/10.1038/s41398-025-03275-w
Vancouver
He Q, Wang W, Zhang Y, Xiong Y, Tao C, Ma L, et al. Global burden of young-onset dementia, from 1990 to 2021: an age-period-cohort analysis from the global burden of disease study 2021. Translational Psychiatry. 2025. doi:10.1038/s41398-025-03275-w. PMID: 39966345.
BibTeX
@article{he2025-b43e77ef,
author = {He, Q. and Wang, W. and Zhang, Y. and Xiong, Y. and Tao, C. and Ma, L. and You, C. and Ma, J. and Jiang, Y.},
title = {{Global burden of young-onset dementia, from 1990 to 2021: an age-period-cohort analysis from the global burden of disease study 2021}},
journal = {Translational Psychiatry},
year = {2025},
doi = {10.1038/s41398-025-03275-w},
pmid = {39966345},
url = {https://doi.org/10.1038/s41398-025-03275-w}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 9 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Global young-onset dementia prevalence rose 211% from 3.7 million (1990) to 7.8 million cases (2021)
- Global young-onset dementia incidence rose 216% from 0.6 million to 1.4 million cases over the same period
- Age-standardized prevalence rose only 2.9% (93.39 to 96.09 per 100,000), indicating most of the raw increase reflects population growth/aging rather than rising per-person risk
- Women had a higher absolute case count (4.28 million vs 3.46 million in men in 2021), though men showed faster rate increases
- The 55-59 and 60-64 age groups accounted for most of the increase in absolute burden
Why it matters
Using three decades of global health data, this study found that the raw number of young-onset dementia cases more than tripled, mostly because there are simply more people in the 55-64 age range worldwide, while a person's underlying risk at a given age rose only slightly. Women carried a higher absolute burden than men, though men's rates were rising somewhat faster.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designmodelling
- Effect sizeGlobal young-onset dementia prevalence rose 211% from 1990 to 2021 (3.7 million to 7.8 million cases); incidence rose 216% (0.6 million to 1.4 million cases); age-standardized prevalence rose modestly from 93.39 to 96.09 per 100,000 (2.9% increase)
- Evidence strengthModerate
Limitations
Relies on modeled GBD estimates built from heterogeneous, often sparse underlying country-level data sources rather than uniformly collected primary surveillance data.
How this study scored 47/100
Published in a peer-reviewed journal, and it is a computer model rather than new measurements. Scored zero for sample size, studied in people, randomized / blinded and indexed in PubMed because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 29 of the 62 points we could judge it on, which is 47 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Translational Psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 3 / 12 | A computer model rather than new measurements |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 0 / 2 | No PubMed ID and no DOI — scores zero (not stated in the record — scored 0) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 29 / 62 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 29 of the 62 points we could judge it on is 47 out of 100. |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 20.
Related studies in How common it is from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.